PMV PHARMACEUTICALS, INC. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
PMV PHARMACEUTICALS, INC. (PMVP) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-03-06
- PMV PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- PMV PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $586.00K.
- PMV PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2019 was $31.00K.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-06 |
| 2024-12-31 | $586.00K 10-K · filed 2026-03-06 |
| 2019-12-31 | $31.00K 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |